Cargando…
Oroxylin A alleviates immunoparalysis of CLP mice by degrading CHOP through interacting with FBXO15
Clinical reports have found that with the improvement of treatment, most septic patients are able to survive the severe systemic inflammatory response and to enter the immunoparalysis stage. Considering that immunoparalysis leads to numerous deaths of clinical sepsis patients, alleviation of the occ...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648083/ https://www.ncbi.nlm.nih.gov/pubmed/33159144 http://dx.doi.org/10.1038/s41598-020-76285-x |